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SUMMARY 
Background: Helicobacter pylori is the most common 
chronic bacterial infection, and a significant 
aetiological factor in acid peptic diseases and gastric 
cancer. Dyspepsia is a common gastrointestinal 
disorder, and the most common indication for 
gastroscopy. Detection of this organism during 
endoscopy has become standard clinical practice. We 
determine the prevalence of H. pylori infection among 
dyspeptic patients using serology and histology.  
Methods: Patients with dyspepsia underwent 
gastroscopy, and biopsies were taken from the antral 
portions of their stomach and processed. Their serum 
samples were tested for H. pylori infection using 
ELISA to detect anti-bodies.  
Results: One hundred and twenty-five patients, 
comprising 49 (39.2%) males and 76 (60.8%) females 
were studied. A prevalence rate of 93.6% for H. pylori 
was found by serology while a rate of 80.0% was found 
by histology.  
Conclusion: There is a high prevalence of H. pylori 
infection in patients with dyspepsia; and a high 
percentage of detection by serological and histological 
tests. 
 




Dyspepsia is a chronic or frequently recurring 
epigastric pain or discomfort which is believed to 
originate in the gastro-duodenal region.1 This may be 
associated with other upper gastrointestinal (GI) 
symptoms such as heartburn, postprandial fullness, and 
early satiety.1 Dyspepsia is a GI disorder, and is the 
most common indication for upper GI endoscopy. 
Helicobacter pylori is a significant aetiological factor 
for acid peptic diseases and gastric cancer. 
Helicobacter pylori testing during upper GI endoscopy 
has become standard clinical practice.2  
 
The prevalence of H. pylori infection worldwide varies 
greatly among countries and among population groups 
in the same country. The infection is more common in 
developing countries where the prevalence rate ranges 
between 70 and 90% as compared to 20-50% in 
developed countries.3 The overall prevalence rate of H. 
pylori infection strongly correlates with low 
socioeconomic status, low living standards, poor 
personal and environmental hygiene, presence of H. 
pylori-positive family members and increasing age.4  
 
In Nigeria, various studies on H. pylori show 
prevalence rates between 73.0% and 94.5% among 
patients with dyspepsia.2,5,6 Endoscopic biopsy of the 
gastric mucosa and serological testing were the 
methods of investigation employed in this study. 
Hence, this study aimed at determining the prevalence 
of H. pylori among dyspeptic patients. 
 
METHODS 
This hospital-based cross-sectional study was carried 
out at the  University of Maiduguri Teaching Hospital, 
North-eastern Nigeria from October, 2006 to March, 
2007. One hundred and twenty-five consecutively 
recruited patients with dyspepsia had upper GI 
endoscopy carried out on them according to standard 
protocol, and biopsies were taken from at least 4 sites 
in the antral portions of their stomach. The specimens 
were fixed in 10% buffered formalin and routinely 
processed with paraffin embedded. The tissues were 
sectioned at 3µm and stained with Haematoxylin and 
Eosin. Modified Giemsa stain was used to demonstrate 
the H .pylori micro-organism. 
 
Serum samples were also collected from the patients  
and tested for H. pylori infection using ELISA to detect 
H. pylori anti-bodies. The bio-data of the patients such 
as age, sex, duration of dyspepsia, history of smoking, 
alcohol and NSAID use were recorded on a proforma. 
Patients who had taken proton pump inhibitors (PPIs) 
in the preceding 2 weeks and/or bismuth containing 
drugs and antibiotics in the preceding 4 weeks were 
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RESULTS 
One hundred and twenty-five dyspeptic patients had 
upper GI endoscopy with endoscopic biopsies. 49 
(39.2%) were males while 76(60.8%) were females, 
giving a male to female ratio of 1:1.6. Their ages 
ranged between 18 and 84 years with a mean age of 
35.3± 12.7 years. Table 1 shows the age distribution of 
all patients with dyspepsia. Majority of the patients 
with dyspepsia were between the third and fourth 
decades of life. 
 
Table 1  The age distribution of patients with 
dyspepsia 













H. pylori was detected in 80.0% of the histologcal 
samples. The presence of H. pylori was indicated in 
93.6% in the patients studied by the serological test.  
 
Concerning  the relationship between the degree of 
activity in chronic gastritis and, positive and negative 
H. pylori infection among patients with dyspepsia, H. 
pylori associated with severe activity accounted for 
16.8%; moderate activity- 43.2%; mild activity - 20% 
and normal gastric mucosa - 6.2%. 
 
DISCUSSION 
Our study was endoscopy-based with the use of 
histology to detect H. pylori, and also serology-based 
which yielded prevalence rates of 80.0% and 93.6% 
among patients with dyspepsia respectively. These 
prevalence rates are similar to those of other 
investigators in our region, and in Nigeria. Holcombe 
et al5 using histology following Haematoxillin and 
Eosin, with modified Giemsa staining of antral biopsies 
in Maiduguri, North-eastern Nigeria found a 
prevalence rate of 84% for H. pylori among their 
patients with dyspepsia. Similarly, Ndububa et al2 
found a prevalence rate of 73% in Ile-ife, South-west 
Nigeria using histology and Campylobacteria-like 
organism (CLO) - urease test on gastric mucosal 
biopsies. 
 
Furthermore, Otegbayo et al6 using serology to detect 
antibodies against H. pylori found a prevalence rate of 
94.5% in Ibadan, South-west Nigeria. A study using 
CLO-urease test in the West Africa sub-region by 
Baako and Darko7 similarly found a high prevalence of 
75.4% of H. pylori infection among Ghanaian patients 
with dyspepsia.  
 
The high prevalence rates found for H. pylori infection 
among dyspeptic patients by various investigators may 
be due to early acquisition of the organism, similarities 
in the age of the patients enrolled, similarities in 
geographical location, socio-cultural practices, 
environmental and living conditions. Bani-Hani et al8 in 
their work in Jordan demonstrated that environmental 
factors such as barometric pressure and seasonal 
temperature variation rather than genetic background 
play a role in the prevalence of H. pylori in different 
populations. Megraud et al3 in their work in France 
showed that H. pylori infection increases with age. A 
similar pattern was also observed by them in Algeria, 
Vietnam and Ivory Coast.  
 
Graham et al9 working in the USA found that the 
prevalence of H. pylori increases with age in both 
developing and developed countries. Pounder and Ng4 
also postulated that the prevalence of H. pylori in a 
community is related to three factors: the rate of 
acquisition of H. pylori infection, the rate of loss of the 
infection, and the prolonged persistence of the 
bacterium in the gastro-duodenal mucosa. Furthermore, 
Castro and Coelho10 postulated that rapid acquisition in 
early life, poor sanitation and low living standards may 
influence the prevalence of H. pylori. 
 
Histology has been considered by some to be the gold 
standard for the detection of H. pylori.11 It however 
depends on a number of factors including the site, 
number, size of gastric biopsies, method of staining, 
and the level of experience of the examining 
pathologist.11 Serology test, however relies on the 
detection of IgG antibodies specific to H.pylori. It 
becomes present approximately 21 days after infection 
and can remain positive for years following successful 
cure of the infection.12 It is therefore of limited benefit 
in documenting eradication of H. pylori. This 
understandably limits its use in clinical practice 
especially in regions of high prevalence of H. pylori 
infection such as the West African sub-region. 
 
In conclusion, our study confirms a high prevalence of 
H. pylori among patients with dyspepsia, and a strong 
correlation between histology and serology in the 
detection of H. pylori. However, the use of serology to 
detect H. pylori infection will be limited in clinical 
practice in the West African sub-region.  
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We therefore suggest an extensive study be carried out 
on H. pylori infection among our populace due to the 
peculiar geographical nature of the region, occupation 
and relationship of the organism with acid-peptic 
diseases and gastric malignancies.  
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